tirzepatide maintenance dosing Tier 1 – 12 Week Supply | Twin Ports Dermatology what is a tirzepatide maintenance

HbA1c fell about 2.0 to 2.6 percentage points and approached its floor by 10 mg, while weight continued responding to higher doses. Participants starting above 8% HbA1c often fell by more than 3 points

More specifically: 19% of people taking 5 mg of Zepbound reported diarrhea

Moreover, TZP induced a considerable average decrease of 53-55% in fasting glucagon levels (adjusted for fasting serum glucose), and a 16-24% decrease in HOMA2-IR, calculated with insulin, highlighting its superior effects on insulin sensitivity

Patients treated with tirzepatide lost an average of 21.1% of their body weight since randomization (co-primary endpoint), compared to an average weight gain of 3.3% over 72 weeks for patients treated with placebo, for a placebo-adjusted net weight change of -24.5%